Clinical Research Directory

Inclusion Criteria: * Adult * Non-febrile * Self-declared member of the Melanesian or European community * Having given consent to participate in the study Exclusion Criteria: * People who have taken part in a clinical study in the last 6 months in which they were exposed to a health product as part of the investigation (pharmaceutical product or device or placebo). * People taking part in an ongoing clinical study * People declaring themselves to belong to two communities (e.g. people of mixed European and Melanesian descent) * Pregnant and breast-feeding women (in whom the immune response could be modified) * People with a long-term medical condition (as defined by the French social security system) that could have an effect on the immune response, excluding dengue risk factors prevalent in New Caledonia such as diabetes, overweight/obesity and hypertension. * Individuals with an acute infection (viral, bacterial or fungal) within 3 months of inclusion. * Chronic administration (for more than 14 days) of immunosuppressants or treatments affecting the immune system in the 6 months prior to inclusion. For corticosteroids, this corresponds to a dose equivalent to 20 mg/day of prednisone or equivalent for more than two weeks (inhaled or topical steroids are permitted). * Administration of a vaccine within 3 months prior to inclusion. * Administration of blood products or immunoglobulins within 3 months of inclusion. * People with known allergies to antibiotics, which could have an impact on the in vitro culture of PBMCs in the presence of antibiotics * Persons not intellectually capable of answering the questionnaire * Persons under guardianship, curatorship or any other legal incapacity